SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020261
Filing Date
2022-05-16
Accepted
2022-05-16 08:41:15
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20220331.htm   iXBRL 10-Q 2177017
2 EX-10.1 logc-ex101_33.htm EX-10.1 212730
3 EX-10.2 logc-ex102_32.htm EX-10.2 377284
4 EX-31.1 logc-ex311_7.htm EX-31.1 18749
5 EX-31.2 logc-ex312_10.htm EX-31.2 18492
6 EX-32.1 logc-ex321_6.htm EX-32.1 7602
7 GRAPHIC gvty0t1we5ya000002.jpg GRAPHIC 3327
8 GRAPHIC gvty0t1we5ya000001.jpg GRAPHIC 3327
9 GRAPHIC gvty0t1we5ya000003.jpg GRAPHIC 3791
  Complete submission text file 0001564590-22-020261.txt   6772982

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA logc-20220331.xsd EX-101.SCH 38761
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20220331_cal.xml EX-101.CAL 43003
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20220331_def.xml EX-101.DEF 105915
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20220331_lab.xml EX-101.LAB 308546
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20220331_pre.xml EX-101.PRE 228745
59 EXTRACTED XBRL INSTANCE DOCUMENT logc-10q_20220331_htm.xml XML 812783
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 22925762
SIC: 2836 Biological Products, (No Diagnostic Substances)